The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs

Commentary on Zhouet al. (2015): Research on methadone maintenance treatment (MMT) as prevention for HCV infection - MMT is not a single variable

(2015) Don C. Des Jarlais   ADDICTION

The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users

(2014) Seonaid Nolan et al.   ADDICTION

Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study

(2014) Bethany White et al.   MEDICAL JOURNAL OF AUSTRALIA

Declining Incidence of Hepatitis C Virus Infection among People Who Inject Drugs in a Canadian Setting, 1996-2012

(2014) Jason Grebely et al.   PLoS One

Reduction in HCV Incidence Among Injection Drug Users Attending Needle and Syringe Programs in Australia: A Linkage Study

(2013) Jenny Iversen et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence

(2011) Katy M. E. Turner et al.   ADDICTION

A Systematic Review and Meta-Analysis of Interventions to Prevent Hepatitis C Virus Infection in People Who Inject Drugs

(2011) H. Hagan et al.   JOURNAL OF INFECTIOUS DISEASES

Reinfection with hepatitis C virus following sustained virological response in injection drug users

(2010) Jason Grebely et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

High incidence of hepatitis C virus reinfection in a cohort of injecting drug users

(2008) Campbell Kynoch Aitken et al.   HEPATOLOGY